Myostatin inhibitors are molecules designed to block the activity of myostatin, thereby promoting muscle growth and hypertrophy. These inhibitors can be small molecules, peptides, or antibodies. By interfering with myostatin signaling, these inhibitors can potentially be used to treat muscle-wasting conditions such as muscular dystrophy, sarcopenia, and cachexia.
